ArticleBritish journal of cancer2014

Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy.

L del Puerto-Nevado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.